Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Psychol Med ; 47(1): 67-80, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27655039

RESUMEN

BACKGROUND: Internet-based cognitive-behavioural treatment (ICBT) for anxiety disorders has shown some promise, but no study has yet examined unguided ICBT in primary care. This randomized controlled trial (RCT) investigated whether a transdiagnostic, unguided ICBT programme for anxiety disorders is effective in primary care settings, after a face-to-face consultation with a physician (MD). We hypothesized that care as usual (CAU) plus unguided ICBT would be superior to CAU in reducing anxiety and related symptoms among patients with social anxiety disorder (SAD), panic disorder with or without agoraphobia (PDA) and/or generalized anxiety disorder (GAD). METHOD: Adults (n = 139) with at least one of these anxiety disorders, as reported by their MD and confirmed by a structured diagnostic interview, were randomized. Unguided ICBT was provided by a novel transdiagnostic ICBT programme ('velibra'). Primary outcomes were generic measures, such as anxiety and depression symptom severity, and diagnostic status at post-treatment (9 weeks). Secondary outcomes included anxiety disorder-specific measures, quality of life, treatment adherence, satisfaction, and general psychiatric symptomatology at follow-up (6 months after randomization). RESULTS: CAU plus unguided ICBT was more effective than CAU at post-treatment, with small to medium between-group effect sizes on primary (Cohen's d = 0.41-0.47) and secondary (Cohen's d = 0.16-0.61) outcomes. Treatment gains were maintained at follow-up. In the treatment group, 28.2% of those with a SAD diagnosis, 38.3% with a PDA diagnosis, and 44.8% with a GAD diagnosis at pretreatment no longer fulfilled diagnostic criteria at post-treatment. CONCLUSIONS: The unguided ICBT intervention examined is effective for anxiety disorders when delivered in primary care.


Asunto(s)
Trastornos de Ansiedad/terapia , Terapia Cognitivo-Conductual/métodos , Internet , Evaluación de Resultado en la Atención de Salud , Atención Primaria de Salud/métodos , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad
2.
Leukemia ; 29(10): 2015-23, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25971364

RESUMEN

Mutations of the tumor suppressor p53 lead to chemotherapy resistance and a dismal prognosis in chronic lymphocytic leukemia (CLL). Whereas p53 targets are used to identify patient subgroups with impaired p53 function, a comprehensive assessment of non-coding RNA targets of p53 in CLL is missing. We exploited the impaired transcriptional activity of mutant p53 to map out p53 targets in CLL by small RNA sequencing. We describe the landscape of p53-dependent microRNA/non-coding RNA induced in response to DNA damage in CLL. Besides the key p53 target miR-34a, we identify a set of p53-dependent microRNAs (miRNAs; miR-182-5p, miR-7-5p and miR-320c/d). In addition to miRNAs, the long non-coding RNAs (lncRNAs) nuclear enriched abundant transcript 1 (NEAT1) and long intergenic non-coding RNA p21 (lincRNA-p21) are induced in response to DNA damage in the presence of functional p53 but not in CLL with p53 mutation. Induction of NEAT1 and lincRNA-p21 are closely correlated to the induction of cell death after DNA damage. We used isogenic lymphoma cell line models to prove p53 dependence of NEAT1 and lincRNA-p21. The current work describes the p53-dependent miRNome and identifies lncRNAs NEAT1 and lincRNA-p21 as novel elements of the p53-dependent DNA damage response machinery in CLL and lymphoma.


Asunto(s)
Apoptosis , Leucemia Linfocítica Crónica de Células B/genética , MicroARNs/genética , ARN Largo no Codificante/genética , Proteína p53 Supresora de Tumor/genética , Anciano , Anciano de 80 o más Años , Western Blotting , Proliferación Celular , Inmunoprecipitación de Cromatina , Daño del ADN , Femenino , Citometría de Flujo , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Pronóstico , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/metabolismo
3.
Med J Aust ; 161(8): 466-70, 1994 Oct 17.
Artículo en Inglés | MEDLINE | ID: mdl-7935117

RESUMEN

OBJECTIVE: To determine the extent of physical and psychological abuse of pregnant women in an Australian population. DESIGN: All women attending the public prenatal clinic of the Royal Women's Hospital (Brisbane) between 23 November and 18 December 1992 were interviewed and asked to complete a self-report questionnaire on their history of abuse. RESULTS: Of 1014 women eligible to enter the study, 301 (29.7%) reported a history of abuse. Fifty-nine (5.8%) had been abused during the pregnancy. The proportion of women admitting to abuse rose over the duration of pregnancy to 8.9% at 36 weeks. Medical treatment was sought for injuries related to domestic violence by 31% of those who reported abuse during the pregnancy. Marital status and education were both significantly associated with the prevalence of abuse. CONCLUSION: Domestic violence towards women may continue or be initiated during pregnancy. RECOMMENDATION: Because most women will not reveal details about their experience of violence in the home unless asked, a relationship history should be included at the first visit along with medical, obstetric and other histories.


Asunto(s)
Embarazo/estadística & datos numéricos , Maltrato Conyugal/estadística & datos numéricos , Adulto , Factores de Edad , Australia/epidemiología , Escolaridad , Femenino , Humanos , Estado Civil , Prevalencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA